TrialBritish journal of pharmacology2020

A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug.

John L Wallace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.